<unk>  (brand name Paradione) is an anticonvulsant in the oxazolidinedione class developed by the Illinois-based pharmaceutical company Abbott Laboratories (known as AbbVie since January 1, 2013 ), and approved by the Food and Drug Administration in 1949 for the treatment of absence seizures, also called partial seizures. In 1960, the yearly cost for 900 mg/day<unk>  was approximately $66, which would translate to $462 yearly in 2007 (with CPI inflation) if<unk>  was still sold.
Paramethadione
Trimethadione
Metenolone
Ethinylestradiol sulfonate
Methandriol propionate
Algestone acetonide
Metenolone acetate
Trestolone